We are delighted to announce our participation in CPHI Frankfurt 2025. This is a fantastic opportunity to connect, collaborate, and explore new possibilities together.
If you would like to schedule a meeting with us, please do so now by filling out the form at the bottom of this page. We look forward to seeing you there!
Modified Phosphoramidites
We are thrilled to announce that Summit Pharmaceuticals Europe is now promoting new modified nucleic acids (phosphoramidites) from Luxna Biotech Co., Ltd.(“Luxna”), a leading biotech company in Japan specializing in the research and development of oligonucleotide therapeutics.
DAIB (Diacetoxyiodo)benzene (CAS 3240-34-4) / DAIM (Diacetoxyiodo)mesitylene (CAS 33035-41-5)
Low-toxic versatile oxidizing agents based on hypervalent iodine. DAIM is particularly suited for use with low-polar solvents.
D-Epoxone (CAS 18422-53-2)
Asymmetric epoxidation catalyst for the production of chiral epoxides. High-purity, heavy metal-free. Eco-friendly production process.
Buchwald Phosphine Ligands
Highly-effective ligands for Pd-catalyzed cross-coupling reactions.
